Could that breast pain be cancer? When to get a mammogram

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainIf you've ever felt pain, tenderness and tightness—maybe even a sharp, stabbing sensation—in your breasts, it's hard not

Updated on: January 02,2024

Could that breast pain be cancer? When to get a mammogram

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainIf you've ever felt pain, tenderness and tightness—maybe even a sharp, stabbing sensation—in your breasts, it's hard not

Updated on:January 02,2024

Advances in multiple myeloma treatment

by Jason Howland, Mayo Clinic News NetworkMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0March is Myeloma Awareness Month. Mul

Updated on: March 20,2024

Advances in multiple myeloma treatment

by Jason Howland, Mayo Clinic News NetworkMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0March is Myeloma Awareness Month. Mul

Updated on:March 20,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on: May 07,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on:May 07,2024

Study suggests new strategies against bone metastases from prostate cancer

by Garth Sundem,CU Anschutz Medical CampusWhen prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 pe

Updated on: June 01,2024

Study suggests new strategies against bone metastases from prostate cancer

by Garth Sundem,CU Anschutz Medical CampusWhen prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 pe

Updated on:June 01,2024

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on: November 15,2024

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on:November 15,2024

New hybrid treatment forces cancer cells to starve

by Greg Williams,NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.The wor

Updated on: January 26,2024

New hybrid treatment forces cancer cells to starve

by Greg Williams,NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.The wor

Updated on:January 26,2024

Genomic testing can identify African American prostate cancer patients who have high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainAfrican American men tend to be diagnosed more frequently with prostate cancer and have higher mortality

Updated on: December 25,2023

Genomic testing can identify African American prostate cancer patients who have high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainAfrican American men tend to be diagnosed more frequently with prostate cancer and have higher mortality

Updated on:December 25,2023

Trial results support 'new gold standard' for head and neck cancer radiotherapy

byInstitute of Cancer ResearchRadiotherapy IMRT. Credit: Jan Chlebik/the ICRPhase III trial results on a precision radiotherapy technique support a "new gold standard" for treating hea

Updated on: January 04,2024

Trial results support 'new gold standard' for head and neck cancer radiotherapy

byInstitute of Cancer ResearchRadiotherapy IMRT. Credit: Jan Chlebik/the ICRPhase III trial results on a precision radiotherapy technique support a "new gold standard" for treating hea

Updated on:January 04,2024

New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment

FEBRUARY 2, 2024 Editors' notesby Germans Trias i Pujol Research InstituteCredit: Unsplash/CC0 Public DomainA team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and

Updated on: March 15,2024

New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment

FEBRUARY 2, 2024 Editors' notesby Germans Trias i Pujol Research InstituteCredit: Unsplash/CC0 Public DomainA team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and

Updated on:March 15,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024

Researchers identify a new way to target treatment-resistant cancers

by Hayley Dunning,Imperial College LondonCredit: ICLAn international team of researchers has found a different way cancer becomes resistant to chemotherapy, suggesting a new target for drugs.Che

Updated on: June 19,2024

Researchers identify a new way to target treatment-resistant cancers

by Hayley Dunning,Imperial College LondonCredit: ICLAn international team of researchers has found a different way cancer becomes resistant to chemotherapy, suggesting a new target for drugs.Che

Updated on:June 19,2024

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023